Chapter 19. Assessing Mitochondrial Protein Synthesis in Drug Toxicity Screening

  1. James A. Dykens2,
  2. Yvonne Will3
  1. Edward E. McKee

Published Online: 22 JAN 2008

DOI: 10.1002/9780470372531.ch19

Drug-Induced Mitochondrial Dysfunction

Drug-Induced Mitochondrial Dysfunction

How to Cite

McKee, E. E. (2008) Assessing Mitochondrial Protein Synthesis in Drug Toxicity Screening, in Drug-Induced Mitochondrial Dysfunction (eds J. A. Dykens and Y. Will), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470372531.ch19

Editor Information

  1. 2

    Pfizer, Inc., Sandwich, UK

  2. 3

    Pfizer, Inc., Groton, Connecticut, USA

Author Information

  1. Indiana University School of Medicine–South Bend, South Bend, Indiana, USA

Publication History

  1. Published Online: 22 JAN 2008
  2. Published Print: 14 SEP 2008

ISBN Information

Print ISBN: 9780470111314

Online ISBN: 9780470372531

SEARCH

Keywords:

  • mitochondrial protein synthesis assessment;
  • drugs and mitochondrial protein synthesis;
  • mitochondrial isolation and respiratory control ratio

Summary

This chapter contains sections titled:

  • Introduction

  • Antibiotics and mitochondrial protein synthesis

  • Methods to assess the effects of drugs on mitochondrial protein synthesis

  • Use of isolated intact mitochondria to assess drug susceptibility of mitochondrial protein synthesis

  • Mitochondrial isolation: quality and the respiratory control ratio

  • Mitochondrial isolation: choice of tissue

  • References